Dissociated response and clinical benefit in patients treated with nivolumab monotherapy
{{output}}
Immune checkpoint inhibitors (ICIs) are effective for previously treated patients with advanced non-small cell lung cancer (NSCLC). However, an unconventional response pattern is sometimes encountered. A dissociated response (DR), characterized by some lesions... ...
